RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM $2B
1-Year Return
22.93%
This Quarter Return
+1%
1 Year Return
+22.93%
3 Year Return
+109.5%
5 Year Return
+168.49%
10 Year Return
+483.96%
AUM
$791M
AUM Growth
+$27.8M
(+3.6%)
Cap. Flow
+$28.4M
Cap. Flow
% of AUM
3.59%
Top 10 Holdings %
Top 10 Hldgs %
34.56%
Holding
211
New
9
Increased
71
Reduced
95
Closed
14
Top Buys
| 1 |
Teladoc Health
TDOC
|
+$3.8M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.29M |
| 3 |
AptarGroup
ATR
|
+$3.22M |
| 4 |
Novartis
NVS
|
+$3.04M |
| 5 |
Illumina
ILMN
|
+$3.03M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$7M |
| 2 |
CVS Health
CVS
|
+$2.14M |
| 3 |
Hologic
HOLX
|
+$1.49M |
| 4 |
Perrigo
PRGO
|
+$1.05M |
| 5 |
Tennant Co
TNC
|
+$956K |
Sector Composition
| 1 | Healthcare | 27.56% |
| 2 | Technology | 21.15% |
| 3 | Industrials | 13.82% |
| 4 | Financials | 10.46% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Prudential Financial
PRU
$37.1B
| $391K | 0.05% |
3,773
-50
| -1% | -$5.18K |
|
152
Sysco
SYY
$38.2B
| $391K | 0.05% |
6,520
| – | – |
|
153
Colgate-Palmolive
CL
$66.4B
| $388K | 0.05% |
5,409
+544
| +11% | +$39K |
|
154
Vanguard Value ETF
VTV
$145B
| $370K | 0.05% |
3,588
-728
| -17% | -$75.1K |
|
155
Air Products & Chemicals
APD
$64.4B
| $369K | 0.05% |
2,320
-50
| -2% | -$7.95K |
|
156
American Express
AXP
$228B
| $366K | 0.05% |
3,920
-700
| -15% | -$65.4K |
|
157
Target
TGT
$40.2B
| $365K | 0.05% |
5,250
+10
| +0.2% | +$695 |
|
158
Adobe
ADBE
$147B
| $364K | 0.05% |
1,685
| – | – |
|
159
Vanguard Real Estate ETF
VNQ
$34.8B
| $362K | 0.05% |
4,801
-900
| -16% | -$67.9K |
|
160
Adient
ADNT
$1.97B
| $359K | 0.05% |
6,003
+1,206
| +25% | +$72.1K |
|
161
Roper Technologies
ROP
$54.4B
| $345K | 0.04% |
1,230
-25
| -2% | -$7.01K |
|
|
CSRA
162
DELISTED
CSRA Inc.
CSRA
| $342K | 0.04% |
8,292
-2,638
| -24% | -$109K |
|
163
T Rowe Price
TROW
$22.9B
| $327K | 0.04% |
3,025
| – | – |
|
164
Walmart
WMT
$827B
| $318K | 0.04% |
10,737
+1,050
| +11% | +$31.1K |
|
165
Baxter International
BAX
$12.2B
| $313K | 0.04% |
4,812
-50
| -1% | -$3.25K |
|
166
Carlisle Companies
CSL
$15.2B
| $313K | 0.04% |
3,000
-500
| -14% | -$52.2K |
|
167
UnitedHealth
UNH
$315B
| $312K | 0.04% |
1,460
+59
| +4% | +$12.6K |
|
168
Vanguard Small-Cap ETF
VB
$67.3B
| $301K | 0.04% |
2,048
-250
| -11% | -$36.7K |
|
169
Berkshire Hathaway Class A
BRK.A
$1.06T
| $299K | 0.04% |
1
| – | – |
|
170
Rollins
ROL
$27.3B
| $296K | 0.04% |
13,073
| – | – |
|
171
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $294K | 0.04% |
2,268
-153
| -6% | -$19.8K |
|
172
Marsh & McLennan
MMC
$97.4B
| $285K | 0.04% |
+3,450
| New | +$285K |
|
173
Match Group
MTCH
$9.02B
| $280K | 0.04% |
+6,300
| New | +$280K |
|
174
iShares Select Dividend ETF
DVY
$20.7B
| $267K | 0.03% |
2,806
+549
| +24% | +$52.2K |
|
175
Idexx Laboratories
IDXX
$51.5B
| $263K | 0.03% |
1,375
-75
| -5% | -$14.3K |
|